How They Differ The differences are entirely in dosage, FDA approval, and marketing : Ozempic (Diabetes Medication) FDA-Approved Use: Treatment of Type 2 Diabetes Mellitus Reducing cardiovascular risk in diabetic patients Dosing Schedule: Starting dose: 0.25 mg weekly (first 4 weeks) Maintenance dose: 0.5 mg or 1.0 mg weekly Maximum dose: 2.0 mg weekly Intended Primary Effect: Blood sugar control A1C reduction Weight Loss Status: Acknowledged as a side effect Not the primary indication Insurance may not cover for weight loss alone Off-Label Use Reality: Many doctors prescribed Ozempic specifically for weight loss before Wegovy became available
Vanhove, K., Derveaux, E., Graulus, G.-J., Mesotten, L., Thomeer, M., Noben, J.-P
Hypoglycemia Despite having a pronounced anti-hyperglycemic effect, GLP-1 RAs are not typically associated with hypoglycemia when used as monotherapy
However, the use of HDACis in non-neoplastic indications is expanding
Northwestern University Gastroparesis Support Group Northwestern University offers a gastroparesis support group, hosted by the Digestive Health Centers Behavioral Medicine Program
Research published in Clinical Immunology explored this further
